276-OR: A 2-Dimensional (2D) Analysis of Glucose and C-Peptide Shows a Teplizumab Effect in Individuals at Risk for Type 1 Diabetes (T1D) 3 Months after Treatment

Journal article

Peer reviewed

EMILY K SIMS, MEGAN V WARNOCK, KEVAN C HEROLD and JAY SOSENKO

Diabetes (New York, N.Y.), Vol.69(Supplement 1), p.276

2020-06

Metrics

6 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 276-OR: A 2-Dimensional (2D) Analysis of Glucose and C-Peptide Shows a Teplizumab Effect in Individuals at Risk for Type 1 Diabetes (T1D) 3 Months after Treatment
Creators: EMILY K SIMS
MEGAN V WARNOCK
KEVAN C HEROLD
JAY SOSENKO
Publication Details: Diabetes (New York, N.Y.), Vol.69(Supplement 1), p.276
Academic Unit: Miller School of Medicine; Diabetes Research Institute (DRI)
Language: English
Resource Type: Journal article
Record Identifier: 991031598977802976